IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Chembio Diagnostics, Inc.
Symbol: CEMI
Price: Last trade $8.45
Trade Date: 7/29
Shares: 1.2 million
Underwriter(s) Craig-Hallum Capital Group
Co Manager(s) The Benchmark Company
Rating=Subscription Needed
Company: Cardiome Pharma Corp.
Symbol: CRME
Price: Last trade $5.30
Description: Re-offer range $3.00-$3.50
Trade Date: 7/26
Shares: 5.7 million shares
Underwriter(s) Leerink Partners
Rating=Subscription Needed
Company: Triangle Capital
Symbol: TCAP
Price: Last trade $20.52
Description: Re-offer range not available at this time.
Trade Date: 7/26
Shares: 6.25 million
Underwriter(s) Morgan Stanley, Keefe, Bruyette & Woods, BofA Merrill Lynch, Robert Baird & Co., BB&T Capital Markets, Janney Montgomery Scott
Co Manager(s) JMP Securities, Wunderlich Securities, Houlihan Lokey Capital
Rating=Subscription Needed
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish